Survey shows over 80% of Europeans have reservations about having laser eye surgery

Article

Germany?s Professor Gerhard Auffarth.

A survey conducted by Opinion Health, 2010 on behalf of The European Society of Cataract and Refractive Surgeons has revealed that 80% of Europeans have reservations about having laser eye surgery themselves despite 69% believing it to be a safe and established procedure.

Approximately, two out of three people cited some degree of fear at the prospect of laser vision correction as the reason for their caution, while about a third said that they would need more information.

ESCRS president José Guell of Barcelona said: “LASIK can be a life changing procedure, but these survey results show that people do not understand just how safe and effective modern LASIK is in the hands of a well qualified and experienced laser eye surgeon. We hope that our new campaign, LASIK Safe in Our Hands will help to bridge the information gap so that more people might benefit from good vision without glasses or contact lenses.”

The survey also highlighted that over 70% of Europeans think that wearing glasses or contact lenses makes it difficult to participate in some sports and nearly 75% think that wearing glasses is inconvenient in different weather conditions. Buying and replacing glasses and contact lenses is perceived to be expensive by 84% of people taking part in the survey (n=1000) but only about a third think that laser eye surgery provides a cheaper alternative if the cost is spread over a ten year period.

www.LASIKSafeinOurHands.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.